Page last updated: 2024-09-04

vatalanib and Fibrosis

vatalanib has been researched along with Fibrosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brun, P; Castagliuolo, I; Chilin, A; Dalla Via, M; Marzaro, G; Palu', G; Schirato, G1
Hirt, SW; Keil, L; Lehle, K; Schaub, AL; Schmid, C; von Suesskind-Schwendi, M1

Other Studies

2 other study(ies) available for vatalanib and Fibrosis

ArticleYear
Substituted quinazolinones as kinase inhibitors endowed with anti-fibrotic properties.
    European journal of medicinal chemistry, 2016, Jun-10, Volume: 115

    Topics: Enzyme Inhibitors; Fibrosis; Molecular Docking Simulation; Quinazolinones

2016
Synergism of imatinib, vatalanib and everolimus in the prevention of chronic lung allograft rejection after lung transplantation (LTx) in rats.
    Histology and histopathology, 2019, Volume: 34, Issue:7

    Topics: Animals; Bronchiolitis Obliterans; Drug Synergism; Everolimus; Fibrosis; Graft Rejection; Imatinib Mesylate; Immunohistochemistry; Lung Transplantation; Phthalazines; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Inbred F344; Rats, Inbred WKY; Receptor Protein-Tyrosine Kinases; Receptor, Platelet-Derived Growth Factor alpha; TOR Serine-Threonine Kinases; Transplantation, Homologous; Vascular Endothelial Growth Factor Receptor-2

2019